CLNN
Clene Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.89
−0.26%Margins
Gross margin
-110.2%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
-8103.5%
159.5%
Return on equity
-171.5%
Return on assets
834.4%
Return on invested capital
0.01x
Asset turnover
-$15.9M
Cash from operations
$0.69
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026